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Abstract
Background: The secretory proteins of Mycobacterium tuberculosis (M. tuberculosis) have been known to be involved in the
virulence, pathogenesis as well as proliferation of the pathogen. Among this set, many proteins have been hypothesized to
play a critical role at the genesis of the onset of infection, the primary site of which is invariably the human lung.
Methodology/Principal Findings: During our efforts to isolate potential binding partners of key secretory proteins of M.
tuberculosis from a human lung protein library, we isolated peptides that strongly bound the virulence determinant protein
Esat6. All peptides were less than fifty amino acids in length and the binding was confirmed by in vivo as well as in vitro
studies. Curiously, we found all three binders to be unusually rich in phenylalanine, with one of the three peptides a short
fragment of the human cytochrome c oxidase-3 (Cox-3). The most accessible of the three binders, named Hcl1, was shown
also to bind to the Mycobacterium smegmatis (M. smegmatis) Esat6 homologue. Expression of hcl1 in M. tuberculosis H37Rv
led to considerable reduction in growth. Microarray analysis showed that Hcl1 affects a host of key cellular pathways in M.
tuberculosis. In a macrophage infection model, the sets expressing hcl1 were shown to clear off M. tuberculosis in much
greater numbers than those infected macrophages wherein the M. tuberculosis was not expressing the peptide.
Transmission electron microscopy studies of hcl1 expressing M. tuberculosis showed prominent expulsion of cellular material
into the matrix, hinting at cell wall damage.
Conclusions/Significance: While the debilitating effects of Hcl1 on M. tuberculosis are unrelated and not because of the
peptide’s binding to Esat6–as the latter is not an essential protein of M. tuberculosis–nonetheless, further studies with this
peptide, as well as a closer inspection of the microarray data may shed important light on the suitability of such small
phenylalanine-rich peptides as potential drug-like molecules against this pathogen.
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Introduction
Tuberculosis (TB), a disease caused byM. tuberculosis, is completely
curable, and yet, two million succumb to it every year [1,2]. In India,
that along with sub-Saharan Africa has the largest number of TB
cases, partial adherence to directly observed drug treatment regimen,
coupled with non-availability of the drugs in remote areas combine
devastatingly to exacerbate the problem, resulting in multi-drug
resistant strains that then de facto necessitate the scientific commu-
nity’s search for newer anti-TB molecules [3–5]. Tied with this
seemingly intractable predicament is the lengthy anti-TB therapy
that lasts on average six to eight months, giving ample opportunity
for poor patients to play truant [6]. The search for new drug-like
molecules against TB that can reduce the length of therapy as well as
address the problem of resistance is, therefore, an urgent one.
As a starting point for our own efforts towards addressing this
urgency, we decided to identify potent protein-protein interactions
that must take place between the secretory proteins of M.
tuberculosis, the carrier of TB, and their human counterparts at
the primary site of infection, the human lung, in order for the
infection to either take root, or, as in many cases, be cleared [7].
Our aim was, once such interactions had been identified, to use de
novo protein/peptide libraries and screen for entities that are able
to disrupt such interactions [8,9]. That some M. tuberculosis
proteins, mostly those that are found in the culture filtrate of M.
tuberculosis–and thus termed ‘the culture-filtrate’ proteins or CFPs–
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that many among this set interact with human lung proteins has
been known for some time [10–14]. A few of such interactions
have also been studied in detail [14–16]; however, no compre-
hensive picture of the infection process has as yet emerged.
Here, we report our investigations with one such secretory
protein, the Esat6 protein that has been implicated in the virulence
and pathogenesis of M. tuberculosis [17–20]. Briefly, Esat6 is a 100
aa long protein that normally exists, indeed is secreted, as a 1:1
complex with its cohort the Cfp10 protein, the latter being also of
roughly equal length [21]. Both proteins are encoded from the
RD1 region of the M. tuberculosis genome, a region that has been
found to be absent in the non-pathogenic strains of mycobacteria,
esp. BCG [19]. Numerous structural and biochemical studies on
this Esat6:Cfp10 complex bear out their all alpha-helical tertiary
fold, the interaction itself a result of hydrophobic-hydrophobic
interactions between the two partners spread over an 1800
angstrom wide surface [22]. Although these proteins are not
crucial for the survival of M. tuberculosis, their absence potently
reduces, in many cases abrogates, the pathogenesis of the bacteria
[18,19,23,24]. More recently, it has been proposed that the 1:1
complex dissociates post secretion, thus leaving Esat6 free to
perform its functions, among which also include induction of host
apoptosis [25,26].
Our aim was to identify any host proteins that interact with free
Esat6 either in a macrophage or in the extracellular matrix, once it
has dissociated from its complex with Cfp10. In this context, we
chose to screen the human lung proteins against Esat6, given that
the primary site of infection is the human lung [7]. Herein, we
report the identification of peptides that strongly bind Esat6 and,
separately, appreciably affect the growth of the pathogen. None
among these peptides were complete human proteins (and could
thus be classified as inhibitors in their own entities); one was a
portion of the mitochondrial Cox-3 protein, while the other two
were formed as a result of aberrant ligation products during cDNA
library construction. Nonetheless, the genes coding for all three
peptides were sequenced and their integrity confirmed. A striking
feature common to all three peptides was the presence of a high
percentage of phenylalanine residues. One of the peptides, Hcl1,
was constitutively expressed inside mycobacterium and its effects
on the bacterial host investigated.
Results
Isolation of Peptides That Bind Esat6
In order to search for host interacting partners of Esat6,
bacterial two-hybrid reporter strain was co-transformed with
esat6pBTnn and human lung cDNA library cloned in pTRG. We
isolated three distinctly blue-coloured colonies, the colour being an
indication that in vivo interaction had occurred. Employing
repeated rounds of plasmid segregations, co-transformations, and
in two cases PCR-amplification of the host gene followed by its re-
ligation with the pTRG plasmid, we were able to confirm the
interaction of the isolated host clones with Esat6 (Fig. 1A). To
further validate the interaction, we performed liquid b-galactosi-
dase assays and found that one of the host genes, named Hcl1, was
a much stronger binder of Esat6 compared with the other two
(Hcl2 and Hcl3; Fig. 1B). When sequenced, Hcl1 indicated an
open reading frame (ORF) corresponding to a 27 amino acid long
peptide (rich in phenylalanine) (Table 1). Interestingly, the ORF
itself was a result of an incorrectly placed adaptor during the
cDNA library construction, when the library members were being
ligated to the recipient pTRG plasmid. A BLAST search showed
that Hcl1 protein shared no homology with any known protein in
the available databases.
Figure 1. Interaction of Esat6 with human cDNA library (HCL) clones. (A) BacterioMatch two-hybrid reporter strain was co-transformed with
(A) hcl1pTRGnn+pBTnn (negative control); (B) hcl1pTRGnn+esat6pBTnn; (C) hcl2pTRGnn+esat6pBTnn; (D) hcl3pTRGnn+esat6pBTnn; and (E)
gal11ppTRG+lgf2pBT (positive control). Two individual colonies from each co-transformant were patched on X-gal indicator plates. (B) Confirmation
of the in vivo interaction between Hcl1 and Esat6 using the liquid b-galactosidase assay. Assays were performed in duplicates with appropriate
controls. Mean6s.d values are displayed here. A similar pattern was observed each time the experiment was repeated.
doi:10.1371/journal.pone.0007615.g001
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Since Esat6 from M. smegmatis (MSMEG_0066) and Esat6 from
M. tuberculosis (Rv3875) share 70% identity, we decided to explore if
Hcl1 could bind M. smegmatis Esat6 as well. Indeed, in an in vivo
bacterial two-hybrid experiment, we found that Hcl1 interacted
with M. smegmatis Esat6 almost as potently as it did with M.
tuberculosis (results not shown). The other two binder peptides, Hcl2
and Hcl3 (Table 1) also displayed an unusually high number of the
Phenylalanine residues. While Hcl3, like Hcl1, was also formed
form an aberrant adapter ligation, analysis of Hcl2 confirmed that
it was part of a larger protein, the human Cox-3. To investigate
whether the full-length human Cox-3 interacts with Esat6, we
synthesized the wild type cox-3 gene and cloned it in pTRGnn
plasmid. We did not detect any interaction between the full-length
Cox-3 and M. tuberculosis Esat6 (results not shown).
Pull-Down Studies
To further validate the interaction between Esat6 and Hcl1, in
vitro pull-down assays were performed. For these assays, Esat6 was
expressed as, separately, FLAG-tagged and His-tagged proteins,
the proteins purified using DEAE-sepharose column under
denaturing conditions and successfully resolubilized. To confirm
the structural and conformational integrity of FLAG-Esat6
protein, we first studied its interaction with M. tuberculosis Cfp10.
Cfp10 was expressed as containing an N-terminal 6X His-tag and
purified as a soluble protein under native conditions using Ni-
NTA agarose column. Additionally, Hcl1 was expressed and
purified as a GST-fusion protein under native conditions using a
glutathione-sepharose column. Equal amounts (10 mg) of the
interacting proteins were used for pull-down experiments. We
found that purified Esat6 interacted with both Cfp10 as well as
Hcl1-GST proteins (Fig. 2A and 2B).
Effect of Hcl1 on the Intracellular Survival of M.
tuberculosis
Once it was confirmed that Hcl1 interacts with Esat6, we decided
to investigate if the peptide has any effect on the intracellular survival
of M. tuberculosis within macrophages. However, first, we cloned hcl1
in another shuttle vector, gfppVV16 that has a C-terminal GFP-tag,
to see if this peptide was expressed in mycobacteria in the first place.
Cells were harvested from log phase cultures of M. tuberculosis
H37Rv, harbouring hcl1gfppVV16 and examined under a fluores-
cent microscope. The green fluorescence, compared with its
complete absence in the pVV16-harbouring control cells clearly
demonstrated to us the expression of Hcl-GFP, also suggesting that
peptides like Hcl1 could be synthesized in mycobacterium (Fig. 3).
Furthermore, a BLAST scan of phenylalanine-rich proteins within
M. tuberculosis revealed that mycobacteria are abundant with proteins
rich in phenylalanine (results not shown).
To study the effect of Hcl1 on the survival of mycobacteria
within human macrophages, THP1 cells were infected with
Table 1. Primary amino acid sequences and characteristics of the peptide binders that interact with Esat6.
peptide sequence aa MW pI % hydr.
Hcl1 AARIRHEGELVSSFFFFFFIENKFNDY* 27 3.3 5.5 41
Hcl2 AAHEGESTYQGHHTPPVQKGLRYGIILFITSEVFFFAGFF* 40 4.5 6.2 33
Hcl3 AARIRIEGTSLEFFFFFFPKKATLLMSCSSVH* 32 3.7 9.3 41
Phenylalanine residues are shown in bold.
Footnotes: aa: amino acids; MW: molecular weight; pI: isoelectric point; % hydr.: percentage hydrophobic content.
*stop codon.
doi:10.1371/journal.pone.0007615.t001
Figure 2. In vitro confirmation of the protein-protein interactions. (A) 16.5% Tricine-SDS polyacrylamide gel stained with coomassie blue
showing interaction between purified Esat6 and Cfp10. Lane 1: pre-stained protein marker, Lane 2: purified His-tagged Cfp10; Lane 3: purified FLAG-
tagged Esat6; Lane 4: 10 mg Cfp10 alone incubated with Ni-NTA agarose and eluted; Lane 5: 10 mg Esat6 alone incubated with 1% PVP blocked Ni-
NTA agarose beads and eluted; Lane 6: empty; Lane 7: 10 mg Cfp10 incubated with Ni-NTA agarose beads and further incubated with 10 mg Esat6,
and subsequently eluted. (B) 16.5% Tricine-SDS polyacrylamide gel stained with coomassie blue showing interaction between Esat6 and Hcl1. Lane 1:
protein marker; Lane 2: purified His-tagged Esat6; Lane 3: purified Hcl1-GST; Lane 4: 5 mg Esat6 incubated with Ni-NTA agarose beads and further
incubated with 5 mg Hcl1-GST, and subsequently eluted; Lane 5: beads initially bound with Esat6 and further incubated with purified GST protein;
Lane 6: purified GST protein.
doi:10.1371/journal.pone.0007615.g002
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mycobacteria harboring either hcl1pVV16 (Mtb/Hcl1) or pVV16
(Mtb/pVV16) at an MOI of 10 for 4 hours at 37uC in an
atmosphere of 5% CO2. Infected THP1 cells were harvested
either immediately after infection (0 hours) or after 24 hours.
THP1 cells were lysed and the mycobacteria plated on
Middlebrook 7H11 agar plates for colony forming unit (CFU)
analysis. Mycobacterial colonies were counted and mean6s.d
values from one experiment were plotted against time (in hours).
Similar pattern was observed each time the experiment was
repeated. A significant reduction in the mycobacterial CFUs was
observed in the sets where THP1 cells were infected with Mtb/
Hcl1, in comparison to where they were infected with Mtb/
pVV16 (Fig. 4)–approximately a 5-fold reduction in the number of
colonies obtained from mycobacteria containing hcl1pVV16 in
comparison to those harbouring just the vector control, pVV16,
immediately after infection (Day 0, Fig. 4A). Although there was a
significant decrease in colony count of mycobacteria one day after
infection (Day 1), a more pronounced, approximately 10-fold
reduction in CFUs was observed in mycobacteria expressing Hcl1,
in comparison to the vector controls (Fig. 4B).
Figure 3. Expression of Hcl1 as a GFP fusion protein in M. tuberculosis. Three individual colonies each from mycobacteria harbouring either
hcl1gfppVV16 (Mtb/GFP-Hcl1) or pVV16 (Mtb/pVV16) were grown till mid-log phase. Cells were examined under a fluorescent microscope. Panel A:
Mtb/GFP-Hcl1 cells; Panel B: Mtb/pVV16 cells. First column in each panel shows bright field image of the sample.
doi:10.1371/journal.pone.0007615.g003
Figure 4. Effect of Hcl1 on survival of mycobacteria within macrophages. THP1 cells were infected with mycobacteria harbouring either
hcl1pVV16 (Mtb/Hcl1) or pVV16 (Mtb/pVV16). The figure shows result of CFU counts, immediately after 4 hours of infection (A), called Day 0 and
24 hours post infection (B), called Day 1. Experiment was performed in triplicates and mean6s.d values are displayed here. A significant decline in the
survival of mycobacteria carrying hcl1pVV16 was observed in comparison to the vector controls.
doi:10.1371/journal.pone.0007615.g004
Anti-Mycobacterial Peptides
PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e7615
Effect of Hcl1 on the In Vitro Growth of M. tuberculosis
To study the effect of Hcl1 on general growth of mycobacteria,
mycobacterial cells were transformed with either hcl1pVV16
(Mtb/Hcl1) or just the vector control, pVV16 (Mtb/pVV16).
Three colonies from each transformant were picked for growth
curve analysis. Optical density of each culture was measured after
every 24 hours and plotted against time (in days) using mean6s.d
(standard deviation) values from one experiment. Similar pattern
was observed each time the experiment was repeated. It was found
that the mycobacteria harbouring hcl1pVV16 showed a signifi-
cant retardation in growth when compared with the vector
controls (Fig. 5). The difference became evident as soon as the cells
entered log phase and lasted till the culture reached stationary
phase.
Effect of Hcl1 on the Cell Morphology of M. tuberculosis
Taking into consideration the effect of Hcl1 on the growth and
intracellular survival of mycobacteria, we decided to investigate
whether Hcl1 has any effect on cell shape and morphology.
Electron micrographs of M. tuberculosis H37Rv cells harbouring
either hcl1pVV16 or pVV16 alone were compared (Fig. 6). Cells
harbouring hcl1pVV16 showed an extensive shedding of extra-
cellular matrix from the surface (Fig. 6B and 6D). These cells with
altered morphology seemed to be devoid of cell coat and appeared
bare.
Effect of Hcl1 on Global Gene Profile of M. tuberculosis
Having seen the effect of Hcl1 on M. tuberculosis growth and cell
morphology, we next performed microarray experiments to
further explore the effects of Hcl1 on mycobacterial cells.
Microarray experiments were performed with three biological
replicates and four on-chip replicates. In order to identify genes
that were differentially regulated in presence of Hcl1, we
compared gene expression profiles of mycobacteria harbouring
either hcl1pVV16 or pVV16 alone. Total RNA was isolated from
log phase cultures of mycobacteria containing either hcl1pVV16
or pVV16, labelled with Cy3/Cy5 dyes and hybridized to
microarray slides containing 4750 oligonucleotides (70-mer), each
representing a unique M. tuberculosis H37Rv gene. Raw intensity
values were transferred to excel spread sheet for analysis using the
Z score method as described previously [29]. Raw intensity data
was normalized using Z score transformation that produced Z
score values for all the genes in each array (Fig. 7). The difference
in average Z score values for all the genes in treated (Mtb/Hcl1)
and control (Mtb/pVV16) was used to calculate the Z ratio. Genes
having a Z ratio .1.5 and p value ,0.05 were considered
significant.
We found differential expression of 176 genes, of which 38 were
found to be significantly upregulated and 138 genes significantly
downregulated (Please see Supplementary Table S1). Of the genes
that were upregulated, there were 7 genes coding for hypothetical
proteins of unknown function, 6 conserved transmembrane
proteins, 3 belonging to PE/PPE_PGRS family, 2 membrane
transporters–one among them being Rv3877, part of Esx-1
secretion system, 2 transposases, 1 transcriptional regulator, 16
involved in various metabolic processes, and a protein kinase
(pknG). Genes that were downregulated contain 84 genes coding
for hypothetical proteins of unknown function, 22 genes involved
in DNA replication, transcription, and translation, 4 belonging to
PE/PPE_PGRS family, 20 genes involved in various metabolic
pathways including cell wall synthesis, 2 genes coding for
conserved transmembrane proteins of unknown function, one
heat shock protein (hspX), 3 genes coding for putative secretory
proteins: Rv0559c, EsxH, and EsxG, one twin-arginine translo-
case protein A (tatA), and a putative protein transporter, secE2.
The differentially expressed genes were compared with the
Rubin’s list of essential genes for in vitro growth and growth within
macrophages [31,32]. We found one gene (pknG) that was found to
be upregulated in our microarray experiment to be an essential
gene required for in vitro growth of M. tuberculosis according to
Rubin and co-workers (Fig. 8). Another gene, Rv3868, coding for
a hypothetical protein, that was found to be upregulated has been
shown to be essential for the growth of mycobacteria within
macrophages (Fig. 8). Similarly, 19 genes that were downregulated
in our experiments were found to be essential for in vitro growth of
mycobacteria according to Rubin and co-workers (Fig. 9); some of
these genes are involved in various metabolic processes including
cell wall synthesis.
Quantitative PCR
To validate our microarray experiments, we carried out real
time PCR analysis of some of the identified genes. The genes
chosen for such analysis were groES (co-chaperonin) and bfrB
(bacterioferritin). The 16S rRNA gene was used as an internal
control to compare the relative expression levels of these genes
between treated (Mtb/Hcl1) and control (Mtb/pVV16) samples.
Both the genes showed approximately 2-fold reduction in Mtb/
Hcl1 samples in comparison to Mtb/pVV16 cells (Fig. 10).
Discussion
In this study, we report isolation and characterization of
phenylalanine-rich peptides that bind Esat6 protein of M.
tuberculosis. Our aim was to study host-pathogen protein-protein
interactions. For this purpose, we screened human lung cDNA
libraries for potential interacting partners of the M. tuberculosis
secretory protein Esat6. Using bacterial two hybrid system, we were
able to isolate three strong binders against Esat6. Two among them,
Figure 5. Effect of Hcl1 on the growth of M. tuberculosis. Three
individual colonies each from mycobacteria harbouring either
hcl1pVV16 (Mtb/Hcl1) or pVV16 (Mtb/pVV16) were picked for growth
curve analysis. Optical density of each culture was measured at 600 nm.
Mean6s.d values are plotted against time (in Days). A similar growth
curve pattern was observed each time the experiment was repeated.
Triangular data points represent OD600 values of Mtb/pVV16 samples;
Squares represent OD600 values of Mtb/Hcl1 samples.
doi:10.1371/journal.pone.0007615.g005
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named Hcl1 and Hcl3, when sequenced, showed that their ORFs
had resulted from incorrectly placed adaptors during the cDNA
library construction, while the third, named Hcl2, was a fragment of
human Cox-3 protein. Table 1 shows the three isolated peptides
and their primary sequence characteristics. Without exception, they
are hydrophobic in nature, possessing at least six to seven
phenylalanine residues. While Hcl1 and Hcl3 display no homology
to any know protein in the database–by virtue of the manner in
which their corresponding ORFs have been formed–Hcl2 on the
other hand is a fragment of the 260 aa long human Cox-3 protein,
that, we showed, does not itself interact with Esat6. Human Cox-3
shares a very high degree of homology with other Cox-3 proteins,
and prominently with the bovine counterpart, where the Hcl2
region is 86% identical to the human Cox-3. Interestingly, Hcl1 and
Hcl3 display an all-helical fold, as seen in their threading models
(results not shown), while Hcl2 fragment is also all-helical in the
bovine Cox-3 protein (pdb code 2EIJ). We showed that the full-
length human Cox-3 does not interact with Esat6, while Hcl2
fragment in isolation does. A closer look at the bovine Cox-3 crystal
structure shows that Hcl2 forms part of a seven-bundle helix that is
the Cox-3 protein; further, Hcl2 is partially embedded within the
whole structure. It should be noted that both, Esat6 and Cfp10 are
all-helical in character and their interaction is principally a
hydrophobic one [22]. Additionally, peptides and proteins rich in
phenylalanine have been seen to adopt helical folds, largely to do
with the aromatic ring stacking [33].
That Esat6 plays an important role in M. tuberculosis virulence is
well studied [17–20]. We decided to investigate the effect of Hcl1
binding to Esat6 and consequently its outcome on the survival of
mycobacteria within macrophages. We noticed a significant
Figure 6. Effect of Hcl1 on cell shape and morphology of M. tuberculosis. Transmission electron micrographs of mycobacterial cells
harbouring either pVV16 (Mtb/pVV16) or hcl1pVV16 (Mtb/Hcl1). Arrow heads in Panel B and D show the difference in cell morphology of
mycobacteria containing Hcl1 when compared with the control (see Panel A and C).
doi:10.1371/journal.pone.0007615.g006
Figure 7. Scatter plot of average Z score values from treated
(Mtb/Hcl1) and control (Mtb/pVV16) samples obtained after Z
score transformation. Data points represent the average Z score
values of genes obtained from six arrays.
doi:10.1371/journal.pone.0007615.g007
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decline in the survival of mycobacteria expressing Hcl1 within
macrophages as indicated by the mycobacterial colony count post
infection. Having studied the binding of Esat6 and Hcl1, both in
vitro and in two-hybrid experiments, it was rational to assume that
the observed effect could be because of this interaction resulting in
the sequestration of Esat6. Esat6 and Cfp10 are part of the same
operon, are co-transcribed and secreted as a tight 1:1 complex by
the Esx-1 secretion system [34,21]. It is possible that the binding of
Hcl1 to Esat6 poses steric hindrance for the interaction between
Esat6 and Cfp10. A second possibility is that the Hcl1-Esat6
complex, when formed, interferes with the normal functioning of
Esat6. Another interesting observation made during this study was
that THP1 cells infected with mycobacteria containing pVV16
alone, showed extensive cell death as indicated by the size of the
cell pellet obtained after the cells were harvested post-infection, in
comparison to the THP1 cells infected with mycobacteria
containing Hcl1. Live M. tuberculosis bacilli and Esat6 as such are
known to induce apoptosis in macrophages [26]. It is possible that
binding of Hcl1 to Esat6 or to some other molecule(s) inside the
cell inhibits this process, although at present there is little proof to
ascertain this conjecture and studies are currently underway to
ascertain the possibility of the above-mentioned scenarios.
Next, we studied the effect of Hcl1 on the in vitro growth of
mycobacteria. We found that mycobacteria containing Hcl1
showed a significant retardation in growth when compared to
the controls. We were initially intrigued by this finding, since Esat6
is not known to play a defined role during the in vitro growth of
mycobacteria [35]. Seeing the effect of Hcl1 on in vitro growth, we
then checked its effect on cell morphology. We found that
mycobacteria containing Hcl1 displayed an altered phenotype
(Fig. 6). These cells showed extensive shedding of extracellular
matrix and appeared bare.
We performed microarray experiments to further study the
effect of Hcl1 on mycobacteria. We found a differential expression
Figure 8. Comparison with Rubin’s lists of genes that were found to be upregulated in microarray experiments. Red circle shows the
genes upregulated; yellow and green circles show the genes essential for in vitro growth and for survival of mycobacteria within macrophages,
respectively.
doi:10.1371/journal.pone.0007615.g008
Figure 9. Comparison with Rubin’s lists of genes that were found to be downregulated in microarray experiments. Red circle shows
the genes upregulated; yellow and green circles show the genes essential for in vitro growth and for survival of mycobacteria within macrophages,
respectively.
doi:10.1371/journal.pone.0007615.g009
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of 176 genes, of which 38 genes were significantly upregulated and
138 genes significantly downregulated. Using the elegant tech-
nique of transposon-based mutagenesis, Rubin and coworkers
have identified sets of genes essential for in vitro growth of M.
tuberculosis as well as for survival within macrophages [31,32]. We
compared the genes differentially regulated in our microarray
experiment with Rubin’s list of genes essential for in vitro growth
and for growth within macrophages. On comparison, we found
that, of the upregulated genes, pknG is essential for in vitro growth of
mycobacteria, and another gene, Rv3868 (coding for a hypothet-
ical protein), essential for survival of mycobacteria within
macrophages. Similarly, 19 genes that were downregulated in
our microarray experiment were found to be common to Rubin’s
list of genes essential for in vitro growth of mycobacteria. Among
these were two genes for putative fatty acid desaturases (desA1 and
desA2), four hypothetical proteins, five ribosomal proteins,
PE_PGRS family protein (PE5), atpF (ATP synthase subunit B),
groES (co-chaperonin), folB (probable dihydroneopterin aldolase),
nadA (quinolinate synthetase), fdxC (probable ferredoxin), thiS
(sulfur carrier protein), and kasB (b-ketoacyl ACP synthase).
Mycobacteria contain a thick protective cell wall chiefly
consisting of an extensively modified fatty acid complex, called
mycolic acid [36]. It has been suggested that acyl desaturases play
a role in the biosynthesis of mycolic acids by introducing position-
specific double bonds that can subsequently be modified [37,38].
Considering the debilitating effect of Hcl1 on cell surface of
mycobacteria, it is tempting to speculate that a downregulation of
desA1 and desA2 could affect mycolic acid biosynthesis and hence
the cell wall integrity. Similarly, it has been shown that a deletion
of kasB (involved in the biosynthesis of meromycolic acids) causes a
change in mycobacterial colony morphology and loss of acid-
fastness [39]. This again correlates well with the observed
alteration in cell envelope of mycobacteria in this study. However,
the effect may not exactly be of the same type as in case of the
DkasB strain, for in our case, it is not a deletion kasB but mere
downregulation. Also, in a recent study, kasB and desA2 were
shown to be significantly downregulated in mycobacteria treated
with vancomycin [40]. The authors suggest that under conditions
of growth arrest, bacteria slow down the synthesis of energy
expensive cell wall components. M. tuberculosis contains one cpn10
(groES) gene present upstream of cpn60.1 (groEL1), which codes for
a 10 kDa partner protein, Cpn10 [41]. Interestingly, it has been
demonstrated that in M. smegmatis, GroEL1 interacts with KasA
and modulates mycolic acid synthesis during biofilm formation,
and a groEL1 mutant of M. smegmatis showed significant reduction
in the levels of KasA and KasB [42]. Since M. tuberculosis encodes a
similar groEL protein and Cpn10 as a helper protein, it is possible
that downregulation of cpn10 could affect the functioning of
Cpn60.1 during mycolic acid synthesis.
Other repressed genes, namely, thiS, fdxC, nadA, atpF, and folB
code for proteins known to be involved in various metabolic
pathways like siderophore biosynthesis, electron transport, NAD
synthesis, ATP synthesis, and folate biosynthesis, respectively. It
seems likely that all genes that were differentially regulated are
directly/indirectly responsible for the observed effects of Hcl1 on
growth and survival of mycobacteria. These findings suggest that
Hcl1 is either working as a general antimicrobial peptide or
interacting with some other molecule(s) inside the cell and hence
interfering with normal cellular processes. As has already been
mentioned, a threading-based modelling predicted a helical
structure for Hcl1, a common feature of many antimicrobial
peptides, and many such peptides have been found to be rich in
phenylalanine residues [43]. However, whereas Hcl1 showed
adverse effects on the growth of M. tuberculosis, it had no visible
effect on the growth of Escherichia coli (E. coli), strengthening our
belief that Hcl1 is interacting with molecule(s) specific to the
mycobacterial cell.
In conclusion, this study demonstrates that Hcl1, a small
peptide unusually rich in phenylalanine residues, affects the
growth and pathogenesis of M. tuberculosis. What remains to be
seen is whether the presence of Hcl1 in mycobacteria hinders
Esat6 secretion. This could be assessed by comparing the levels of
Esat6 protein in the culture filtrate of mycobacteria with and
without Hcl1. Also, a pull-down assay from mycobacterial cell
lysate is likely to shed some light on what might be many
mycobacterial interacting partners of Hcl1. The localization of
Esat6, in the presence and absence of Hcl1, within infected
macrophages would also, we believe, shed new light on the
possibility that Esat6 is involved in a hitherto unknown mechanism
that helps the mycobacteria evade the host immune apparatus to a
large extent. Finally, we hope that these studies might provide
important clues regarding the mechanism of action of Hcl1 and
other such phenylalanine-rich peptides and the information thus
obtained could be further utilized in designing/improving peptide-
based inhibitors against M. tuberculosis.
Materials and Methods
Bacterial Two-Hybrid Studies
BacteriomatchTM two-hybrid system vector kit and Bacterio-
matchTM Reporter strain competent cells were purchased from
Stratagene, USA. The BacteriomatchTM kit was supplied with
bacterial two-hybrid system plasmids pBT, pTRG and control
plasmids pBT-LGF2 and pTRG-Gal11p. The human lung cDNA
library (cloned in pTRG vector) was purchased from Stratagene,
USA. The bait and target expression vectors were modified to
have a unique SnaBI site in its MCS for blunt end clonings [8].
Figure 10. Relative fold change in the transcript levels of bfrB
and groES genes. Real-time PCR was done using SYBR Green dye. Both
genes were found to be significantly downregulated (,2-fold) in Mtb/
Hcl1cells when compared with the mycobacteria harbouring only
pVV16. Experiment was performed using two biological replicates and
in duplicates.
doi:10.1371/journal.pone.0007615.g010
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The full length gene for esat6 (Rv3875) was amplified from M.
tuberculosis H37Rv genomic DNA using forward (59-CCT ACG
TAA TGA CAG AGC AGC AGT GGA A-39) and reverse (59-
CCT ACG TAT GCG AAC ATC CCA GTG ACG T-39)
primers, and cloned in pBTnn vector. Also, the corresponding
homologue of esat6 (MSMEG_0066) from M. smegmatis LR222 was
amplified from genomic DNA using the forward (59-CCG AAT
TCT ACG TAA TGA CAG AAC AGG TAT GGA ATT TC-39)
and reverse primers (59-CCG AAT TCT ACG TAG GCA AAC
ATT CCC GTG ACG CCG GCC-39) and cloned in pBTnn.
Reporter strain competent cells were co-transformed with equal
amounts (250 ng each) of esat6pBTnn and human lung cDNA
library and plated on X-Gal indicator plates containing kanamycin
(50 mg/ml), chloramphenicol (30 mg/ml), tetracycline (12.5 mg/
ml), X-Gal (80 mg/ml), IPTG (25 mM), and X-Gal inhibitor
(200 mM). Plasmids pBT-LGF2 (lcI-LGF2 fusion) and pTRG-
Gal11p (RNAPa subunit-Gal11p fusion) provided the positive
controls, whereas empty pBTnn and pTRGnn plasmids served as
negative controls for all in vivo interaction studies. Positive
interactions were judged by the blue colour of the colonies
obtained and further verified by repeated clonings and cotrans-
formations. The interactions were further verified by performing
liquid b-galactosidase assay as described earlier [27].
Cloning of hcl1, Esat6, and Cfp10 for Protein Expression
Forward (59-AAG GAT CCT ACG TAA GAA TTC GGC
ACG AG-39) and reverse (59-AAG GAT CCT ACG TAA TAA
TCA TTA AAC TT-39) primers were used to amplify the ORF
corresponding to Hcl1 protein from the original lung cDNA
library clone. The PCR product was digested and cloned in SnaBI
site in pGEX4T3nn vector [8] resulting in a fusion protein with a
C-terminal GST tag. The esat6pBTnn plasmid DNA was digested
with NotI/BglII and the resulting 346 bp fragment was cloned in
NotI/BamHI-digested pFLAGCMV6a vector to obtain esat6p-
FLAGCMV6a. The esat6pFLAGCMV6a plasmid DNA was
digested with NcoI/EcoRI and a 359 bp fragment was cloned in
NcoI/EcoRI-cut pET28a (Novagen) vector. The clone, flagesat6-
pET28a, resulted in expression of Esat6 as a fusion protein with an
N-terminal FLAG-tag but no His-tag. The ORF corresponding to
Cfp10 protein was PCR amplified from M. tuberculosis H37Rv
genomic DNA using forward (59- CCT ACG TAA TGG CAG
AGA TGA AGA CCG A-39) and reverse (59- CCT ACG TAA
GTA CTG AAG CCC ATT TGC GAG GAC A-39) primers. The
PCR product was digested with SnaBI and cloned in SnaBI-cut
pBADHisAnn vector. The clone, cfp10pBADHisAnn, resulted in
expression of Cfp10 as fusion protein with a C-terminal 6x His-
tag. Similarly, for the expression of Esat6 with a C-terminal 6X
His-tag, the ORF was amplified as described above from H37Rv
genomic DNA and cloned in pBADHisAnn vector.
Protein Expression and Purification of Hcl1-GST
E. coli BL21 (DE3) (Novagen) cells harbouring hcl1pGex4T3nn
were grown till mid-log phase and induced with 1 mM IPTG for
3 hours with constant shaking at 37uC. Cells were harvested and
the pellet was washed with PBS (40 mM K2HPO4, 10 mM
KH2PO4, 150 mM NaCl, pH 7.2). Cell pellet was resuspended in
(1% of the original culture volume) lysis buffer (100 mM EDTA,
1 mM PMSF, 0.5 mM DTT in PBS) and sonicated till a clear
lysate was obtained. Triton X-100 was added to a final
concentration of 1% and the tubes were incubated at 4uC for 30
minutes with constant shaking. Lysate was then centrifuged and
the clear supernatant was transferred to fresh tubes. Glutathione-
agarose beads (Amersham) were washed thrice with PBS. Desired
amount of glutathione-agarose beads were added to the superna-
tant and incubated at 4uC for 3 hours with constant shaking.
Flow-through was collected and beads were washed thrice with
PBS containing 1% Triton X-100 followed by a single wash of 50
volume of TN buffer (50 mM tris-Cl, 150 mM NaCl, pH 7.5).
Resin bound proteins were eluted using elution buffer (10 mM
reduced glutathione in 50 mM tris-Cl, pH 8.0) and analyzed on
SDS-PAGE. Purified protein was dialyzed against PBS, pH 7.5,
quantified and stored at 220uC in aliquots.
Protein Expression and Purification of Esat6
E. coli BL21 (DE3) cells harbouring flagesat6pET28a were grown
till mid-log phase and induced with 1 mM IPTG for 3 hours with
constant shaking at 37uC. Cells were harvested and the pellet was
washed with PBS. Cell pellet was resuspended in lysis buffer (8 M
urea in 40 mM phosphate buffer, pH 7.5) and sonicated till a clear
lysate was obtained. The lysate was centrifuged and the supernatant
was transferred to a fresh tube. The supernatant was mixed with
DEAE-sepharose (Amersham) and incubated at room temperature
for 1.5 hours with constant shaking. Beads were washed thrice with
lysis buffer and the resin bound proteins were eluted using a
gradient of NaCl from 0 M to 1 M, prepared in lysis buffer. The
gradient elution was performed using AKTA FPLC (Amersham)
system and the eluted fractions were analyzed on SDS-PAGE. For
purification of His-tagged Esat6, log phase culture of E. coli TOP10
(Invitrogen) cells containing esat6pBADHisAnn were induced with
0.02% L-arabinose for 3 hours at 37uC. Cells were pelleted and
washed with PBS. Pellet was resuspended in lysis buffer (100 mM
NaH2PO4, 10 mM tris-Cl, pH 8.0 and sonicated. Lysate was
cleared by centrifugation and pellet thus obtained was solubilized in
lysis buffer containing 8 M urea, 10 mM imidazole, and 1% Triton
X-100. Solution was centrifuged and supernatant was loaded on a
Ni-NTA agarose (Qiagen) column. Beads were washed once with
buffer B and thrice with buffer C (buffer B containing 20 mM
imidazole). Finally, protein was eluted using elution buffer (100 mM
NaH2PO4, 10 mM tris-Cl, 8 M urea, 350 mM imidazole, pH 8.0).
Purified protein was refolded by sequentially and slowly dialyzing it
against PBS with decreasing concentration of urea. Protein was
concentrated using AmiconH Ultra (Millipore) column, quantified
and stored at 220uC in aliquots.
Protein Expression and Purification of Cfp10
E. coli TOP10 cells harbouring cfp10pBADHisAnn were grown
till mid-log phase and induced with 0.02% L-arabinose for 3 hours
at 37uC. Cells were pelleted and resuspended in lysis buffer
(50 mM NaH2PO4, 300 mM NaCl, and 10 mM imidazole,
pH 8.0). Lysozyme was added to a final concentration of 1 mg/
ml and tubes were incubated at 4uC for 30 minutes with shaking.
Samples were sonicated till a clear lysate was obtained. Triton X-
100 was added to a final concentration of 1% and incubated at
4uC for 30 minutes with shaking. Lysate was centrifuged and the
supernatant was loaded on a Ni-NTA agarose column. Beads were
washed once with lysis buffer and thrice with wash buffer (50 mM
NaH2PO4, 300 mM NaCl, and 20 mM imidazole, pH 8.0).
Protein was eluted using elution buffer (50 mM NaH2PO4,
300 mM NaCl, and 300 mM imidazole, pH 8.0), dialyzed against
PBS, quantified and stored at 220uC.
In Vitro Protein-Protein Interaction
Esat6 and Cfp10. Ni-NTA agarose beads were mixed with
10 mg of purified Cfp10-His protein and incubated at 4uC with
shaking for 1.5 hours. Beads were washed twice with 50 mM
phosphate buffer containing 500 mM NaCl (wash buffer 1) and
once with PBS containing 0.1% Tween-20 and 14 mM b-
mercaptoethanol (wash buffer 2). Beads were then blocked with
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1% polyvinyl pyrrolidone (PVP) for 1 hour. To this, 10 mg of
purified FLAG-Esat6 protein was added and incubated at 4uC for
1.5 hours. In a control experiment, Ni-NTA agarose beads were
blocked with 1% PVP and incubated with 10 mg of purified
FLAG-Esat6 protein at 4uC for 1.5 hours. Finally, beads were
extensively washed with wash buffer 1. Resin bound proteins were
eluted by boiling the beads in 2X SDS loading dye (20% glycerol,
4% SDS, 125 mM tris-Cl, pH 6.8, and 4% b-ME) and resolved
on 16.5% tricine-SDS polyacrylamide gel.
Esat6 and Hcl1. Purified His-tagged Esat6 protein (10 mg)
was incubated with Ni-NTA agarose beads for 1.5 hours at 4uC.
Beads were washed twice with buffer B (100 mM NaH2PO4,
10 mM tris-Cl, 20 mM imidazole, pH 7.4) followed by two washes
with buffer B containing 30 mM imidazole and finally one wash
with buffer C (30 mM imidazole in PBS, pH 7.4). To the beads,
10 mg purified Hcl1-GST protein was added and kept for binding
at 4uC for 1.5 hours. In a control experiment, 10 mg purified GST
protein was added to Esat6 bound Ni-NTA agarose beads. Beads
were finally washed twice with buffer C and bound proteins were
eluted by boiling the beads with 2X SDS loading dye and resolved
on 16.5% tricine-SDS polyacrylamide gel.
Construction of Expression Vectors
pVV16SnaBI (called pVV16) vector. The original pVV16
vector was modified to have a unique SnaBI site in its MCS for blunt-
end clonings. Forward (59-CCC CAT GGC ATA TGT ACG TAA
TGATTGATGAGGCTCTCTTCGA-39) and reverse (59-CCC
TCG AGA AGC TTT ACG TAG ACC TCC AGC AGC TCG
CCT TC-39) primers were designed to amplify a 599 bp fragment
from frrpBTnn. Amplified PCR product was digested with NdeI/
HindIII and cloned in NdeI/HindIII-digested pVV16 vector. The
resulting clone, frrpVV16 was digested with SnaBI to remove the
insert and self-ligated to generate, pVV16SnaBI. The gene
corresponding to hcl1 was amplified from original lung cDNA
library clone using forward (59-AAG GAT CCT ACG TAA GAA
TTC GGC ACG AG-39) and reverse (59-AAG GAT CCT ACG
TAATAATCATTAAACTT-39) primers, digested with SnaBI and
cloned in pVV16 to generate hcl1pVV16.
gfppVV16SnaBI (called gfppVV16) vector. Forward (59-
CCG AAT TCT ACG TAA TGG TGA GCA AGG GCG AGG
AGC TG-39) and Reverse (59-CCG AAT TCA GTA CTT TAC
TTG TAC AGC TCG TCC ATG CC-39) primers were used to
amplify 748 bp GFP gene using pGFPN1 (Clontech) as template.
The PCR product was digested with SnaBI/ScaI and cloned in
SnaBI-cut pVV16 vector to generate gfppVV16SnaBI. The
resulting vector had a unique SnaBI site upstream of gfp gene.
The gene corresponding to hcl1 was amplified as described above
and cloned in SnaBI-cut gfppVV16 to generate hcl1gfppVV16.
Expression of Hcl1 in M. tuberculosis
Mycobacteria harbouring either hcl1gfppVV16 or pVV16 were
grown till mid-log phase. Cells were harvested, washed with PBS
and fixed by treating with a 2% paraformaldehyde solution for
1 hour at 4uC [28]. Cells were examined using advanced inverted
microscope, ECLIPSE TE 2000-S (Nikon) for GFP fluorescence.
Infection of Human Macrophages with M. tuberculosis
THP1 cells were grown in RPMI 1640 media supplemented with
10% fetal bovine serum. Cells were seeded in flat bottom culture
flask at a confluence of around 80% and induced with 50 ng/ml
phorbol-12-myristate-13-acetate (Sigma) for 12 hours. Activated
THP1 cells were infected (MOI=10) with M. tuberculosis H37Rv
bacilli harbouring either hcl1pVV16 or pVV16, for 4 hours at
37uC, in an atmosphere of 5% CO2. Cells were harvested and
washed with pre-warmed medium to remove extracellularly present
bacteria. Additionally, cells were treated with gentamicin (Sigma,
50 mg/ml) for 2 hours at 4uC to kill extracellularly present bacteria.
Finally, cells were washed, resuspended in PBS and lysed with 1%
NP-40 by vortexing. Supernatant was diluted and plated on
Middlebrook 7H11 agar (DifcoTM, BD) plates supplemented with
10% OADC (BBLTM, BD), 100 mg/ml cycloheximide, 0.5%
glycerol, and 25 mg/ml kanamycin. The plates were incubated at
37uC till the colonies appeared.
Growth Curve Studies of M. tuberculosis
Mycobacteria harbouring hcl1pVV16 (Mtb/Hcl1) or pVV16
(Mtb/pVV16) were grown in 10 ml Middlebrook 7H9 broth at
37uC and 200 rpm till stationary phase was reached. Optical
density of the culture was measured at 600 nm using Lambda 35
spectrometer (PerkinElmer) and equal numbers of cells from each
culture were freshly inoculated in 50 ml flask containing fresh
Middlebrook 7H9 broth. Cells were allowed to grow at 37uC and
200 rpm. Optical density of each culture was measured at 600 nm
after every 24 hours.
Transmission Electron Microscopy
M. tuberculosis H37Rv cells harbouring either hcl1pVV16 or
pVV16 were grown (at 37uC with constant shaking) till mid-log
phase in Middlebrook 7H9 broth (DifcoTM, BD), supplemented
with 10% ADC (BBLTM, BD), 0.05% Tween-80, 0.2% glycerol,
and 25 mg/ml kanamycin. Cells were harvested, washed with PBS
and fixed by treating with 2% paraformaldehyde solution for
1 hour at 4uC [28]. Fixed cells were allowed to adsorb on a 300
mesh copper grid and air dried. Samples were then stained with
1% uranyl acetate for 30 seconds and photographed using a FEI
Tecnai 12 Electron Microscope.
Total RNA Isolation from M. tuberculosis
Total RNA was isolated as described previously [8] with some
modifications. Cells were harvested from exponentially growing
mycobacteria harbouring either hcl1pVV16 (Mtb/Hcl1-treated
sample) or pVV16 (Mtb/pVV16-control sample) and washed with
0.1% Tween 20. Pellet was resuspended in 400 ml TES buffer
(50 mM Tris-Cl, pH 7.4, 10 mM EDTA, and 1% SDS). To this an
equal volume of water-saturated phenol was added. Approximately
an equal volume of acid-washed glass beads was added for efficient
cell disruption. Tubes were vigorously vortexed and incubated at
65uC for 1 hour with intermittent vortexing after every 15 minutes.
Finally, the tubes were chilled on ice for 5 minutes and centrifuged
at 13,000 rpm for 15 minutes at 4uC. Aqueous phase was
transferred to fresh tubes and extracted thrice with chloroform:
isoamylalcohol (24:1). RNA was precipitated with 0.1 volume of
3 M sodium acetate and 2.5 volume of chilled ethanol. For efficient
precipitation of RNA, tubes were incubated at 280uC for 30
minutes and centrifuged at 13,000 rpm for 30 minutes at 4uC. RNA
pellet was washed with 70% ethanol, dried and resuspended in
30 ml of DEPC-treated water. RNA was checked for quality on 1%
denaturing agarose gel and purified using RNeasy purification kit
(Qiagen) followed by on-column DNaseI (0.7 U/ml) (Ambion)
treatment for 30 minutes at room temperature, as described by
the manufacturer. RNA was checked for quantity and quality on a
NanoDropTM ND-1000 spectrophotometer (Thermo Scientific).
Labeling of cDNA with Cy Dyes
Equal amounts of RNA (9.0 mg) from both control (Mtb/
pVV16) and treated (Mtb/Hcl1) samples were used for preparing
labeled cDNA for microarray experiment. Total RNA was labeled
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with Cy3/Cy5-dUTP using CyScribe First-Strand cDNA labeling
kit (Amersham) as described by the manufacturer. Labeled
product was treated with RNaseA (0.03 U/ml) (Fermentas) and
RNaseH (0.05 U/ml) (Fermentas) for 20 minutes at 37uC to remove
the RNA. Labeled cDNA was purified and eluted using MinElute
PCR Purification kit (Qiagen) and analyzed on a NanoDropTM
spectrophotometer for quantity and quality. Incorporation of Cy3
and Cy5 dye was determined by measuring the absorbance at
550 nm and 650 nm, respectively. Labeled cDNA was vacuum
dried and stored at 220uC till further use.
Microarray Slides Hybridization
M. tuberculosisH37Rv microarray slides (Version 4) were obtained
from Pathogen Functional Genomics Resource Center (PFGRC), J.
Craig Venter Institute (JCVI). The hybridization protocol used here
is as described by The Institute for Genomic Research, SOP#8
(http://pfgrc.jcvi.org/index.php/microarray/protocols.html) with
some minor modifications. The slides were incubated in pre-
warmed (at 42uC) pre-hybridization buffer (5X SSC, 0.1% SDS,
1% BSA) and incubated at 42uC for 1 hour in 50 ml Falcon tubes.
The slides were thoroughly rinsed with distilled water followed by
isopropanol and quickly dried by centrifugation at 1,500 rpm for 15
minutes. The labeled cDNA probe was resuspended in 50 ml
hybridization buffer (5X SSC, 40% formamide, 0.1% SDS,
0.1 mMDTT, 0.6 mg/ml salmon sperm DNA). This probe mixture
was vortexed and heated at 95uC for 5 minutes, vortexed and then
again heated at 95uC for another 5 minutes. The denatured probe
mixture was then added to the slides and covered with a coverslip.
The hybridization cassette (Corning) was sealed and submerged in a
water bath set at 42uC for 20 hours. Post hybridization, coverslips
were removed and slides were washed 5 times with pre-warmed (at
55uC) Low Stringency Wash buffer (2X SSC, 0.1% SDS, 0.1 mM
DTT). Slides were then washed 5 times with Medium Stringency
Wash buffer (0.1X SSC, 0.1% SDS, 0.1 mM DTT). Finally, slides
were washed five times with High Stringency Wash buffer (0.1X
SSC, 0.1 mM DTT) and thoroughly rinsed with distilled water.
Slides were dried by centrifugation at 1,500 rpm for 15 minutes and
stored under dark and dry conditions.
Microarray Data Analysis
Slides were scanned using a dual laser ScanArray Gx Scanner
(PerkinElmer) at best signal and least noise PMT gain. ScanArray
Express (PerkinElmer) software was used to convert the hybridiza-
tion signals into raw intensity values, which were then transferred to
Microsoft Excel spreadsheet for further analysis. Data analysis was
done using Z-score method described previously [29]. Raw intensity
data for Cy3/Cy5 dyes (for both Mtb/pVV16-control as well as
Mtb/Hcl1-treated samples) as ‘mean-background’ was extracted
from six arrays and used for normalization. Raw intensity values
were log10 transformed and average and standard deviation
calculated for all the genes in each replicate and across all the
arrays. Z-score values were calculated by subtracting the overall
average intensity from log10 transformed raw intensity and dividing
by measured standard deviation in a single experiment and for all
replicates. Average of all the replicates for both treated (Mtb/Hcl1)
and control (Mtb/pVV16) samples were used to calculate Z-Score
difference (Treated-Control). Test of significance for changes in
gene expression was measured by calculating the Z-ratios and p
values in a standard T-test (two class unpaired, two tailed). Z-ratios
were calculated by measuring the difference between the average Z-
score of genes from treated samples (Mtb/Hcl1) and from control
samples (Mtb/pVV16) and dividing them by the standard deviation
of the difference. Genes having a Z-ratio .1.5 and p value ,0.05
were considered significant.
The microarray data is MIAME compliant and has been
deposited in a MIAME compliant database GEO (Accession
No. GSE16618).
Real Time PCR
5.0 mg RNA from both control (Mtb/pVV16) and treated
(Mtb/Hcl1) samples was reverse transcribed using CyScribe First
strand cDNA labeling kit (Amersham). Random nonamer primers
were added to RNA sample in a total volume of 11 ml. This
mixture was heated at 70uC for 5 minutes and then allowed to cool
for 10 minutes at room temperature. Subsequently, 4 ml of 5X
CyScribe buffer, 1 ml of 100 mM DTT, 1 ml of 10 mM dNTPs,
and 1 ml of CyScribe reverse transcriptase were added in a total
volume of 20 ml. Reaction mixture was incubated at 42uC for
1.5 hours. Reaction was stopped by inactivating the enzyme at
90uC for 10 minutes. Real time PCR was performed using IQ
SYBR Green Supermix (BioRad) in a total reaction volume of
25 ml. The reaction mixture consisted of 0.4 mM of each primer,
12.5 ml of 2X IQ SYBR Green Supermix, and 1 ml of diluted
cDNA template (equivalent to 8 ng RNA). Amplification was
performed in a MiniOpticon (BioRad) thermocycler using
following conditions: (i) an initial denaturation step of 10 minutes
at 95uC; (ii) 40 cycles, each consisting of 30 seconds at 95uC, 30
seconds at 58uC, and 30 seconds at 72uC. Fluorescence was
measured at the end of the elongation step during each cycle. A
melt curve analysis was performed between 55uC and 95uC with
an increment of 0.5uC per 10 seconds. PCR product was also
checked on 1.7% agarose gel. Data was analyzed using
comparative CT method as described earlier [30]. 16S rRNA
was used as an internal control gene for normalization.
Supporting Information
Table S1 Differentially regulated genes in microarray experiments.
Found at: doi:10.1371/journal.pone.0007615.s001 (0.05 MB
XLS)
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